TickerFacts.

Galmed Pharmaceuticals Ltd. (EOCN): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$18.50M
Year ended 2022-12-31
2012-12-31: -$3.11M2013-12-31: -$2.54M2014-12-31: -$10.01M2015-12-31: -$8.63M2016-12-31: -$12.15M2017-12-31: -$12.08M2018-12-31: -$9.11M2019-12-31: -$14.95M2020-12-31: -$26.33M2021-12-31: -$32.90M2022-12-31: -$18.50M-$18.50M
2012-12-31 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$18.50Mn/m2025-04-02, From 2022-01-01
2021-12-31-$32.90Mn/m2024-04-04, From 2021-01-01
2020-12-31-$26.33Mn/m2023-03-29, From 2020-01-01
2019-12-31-$14.95Mn/m2022-05-02, From 2019-01-01
2018-12-31-$9.11Mn/m2021-03-18, From 2018-01-01
2017-12-31-$12.08Mn/m2020-03-12, From 2017-01-01
2016-12-31-$12.15Mn/m2019-03-13, From 2016-01-01
2015-12-31-$8.63Mn/m2018-03-13, From 2015-01-01
2014-12-31-$10.01Mn/m2017-03-23, From 2014-01-01
2013-12-31-$2.54Mn/m2016-03-22, From 2013-01-01
2012-12-31-$3.11Mn/a2015-03-31, From 2012-01-01